Gender

Male

Location

Mobile, AL

Birthday:

October 22

Age:

46

I am...

Biologist, Doctor

My research field or area of interest innanotechnology

Nanomedicine, Pancreatic Cancer, Skin Cancer

Interest in...

Anti-cancer and chemo-preventive activity of natural compounds,Identification and characterization of novel therapeutic targets against cancer,Development of novel nano-delivery system to target cancer cells,Nanotoxicology, silver nanoparticles

Publication list

1. Arora, S., Tyagi, N., Deshmukh S. K., Singh, S., Marimuthu, S., Singh, A.P. (2015). Mission possible: Exploiting nanoways for the development of microRNA-based cancer therapeutics. Journal of Biomedical Nanotechnology (Accepted for publication) 2. Arora, S., Tyagi, N., Bhardwaj, A., Rusu, L., Palanki, R., Vig, K., Singh S.R., Singh A.P., Palanki, S., Miller, M. E., Carter J.E., Singh, S. (2015). Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine: Nanotechnology, biology and Medicine. 11:1265–1275. 3. Arora, S., Swaminathan, S.K., Kirtane, A., Srivastava, S.K., Bhardwaj, A., Singh, S., Panyam, J., Singh, A.P. (2014). Synthesis, characterization, and evaluation of poly (D, L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine. 9:2933-42. 4. Arora, S., Bhardwaj, A., Singh, S., Srivastava, S.K., McClellan S., Nirodi C.S., Piazza, G.A., Grizzle W.E., Owen, L, B., Singh, A.P., (2013). An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated upregulation of CXCR4. Journal of Biological chemistry. 288(29):21197-207. 5. Arora, S., Singh, S., Piazza, G.A., Contreas, C.M., Panyam, J., and Singh, A.P. (2012). Honokiol: a novel natural agent for cancer prevention and therapy. Current Molecular Medicine. 12 (10); 1244-1252. 6. Arora, S., Rajwade, J.M., Paknikar, K.M., (2012). Nanotoxicology and in vitro studies: the need of the hour. Toxicology and applied pharmacology. 258:151-165. 7. Arora, S., Bhardwaj, A., Srivastava, S., Singh, S., McClellan, S., Wang, B & Singh, A.P. (2011). Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS ONE. 6 (6): e21573. 8. Arora, S., Jain, J.,Rajwade, J.M., Paknikar, K.M., (2009). Interactions of silver nanoparticles with primary mouse fibroblast and liver cells. Toxicology and applied pharmacology, 236, 310-318. 9. Arora, S., Jain, J., Rajwade J.M., Paknikar K.M., (2008). Cellular responses induced by silver nanoparticles: in vitro studies. Toxicology Letters, 179, 93-100. 10. Khan M.A., Srivastava S.K., Bhardwaj A., Singh S., Arora S., Zubair H., Carter J.E., Singh A.P. (2015). Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Oncotarget. (Accepted for publication) 11. Srivastava S.K, Bhardwaj A., Arora S., Tyagi N., Singh A.P., Carter J.E, Scammell J.G, Fodstad Ø, Singh S. (2015). Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. British journal of cancer. 112(11):1772-1781. 12. Srivastava, S.K., Arora, S., Averett, C., Singh, S., Singh, A.P. (2015). Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance. BioMed Research International. 2015,1-9. 13. Bhardwaj, A., Srivastava, S.K., Singh, S., Arora, S., Tyagi, N., Andrews, J., McClellan, S., Carter, J.E., Singh, A.P. (2014). CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1. Oncotarget. 5 (22):11490-500. 14. Bhardwaj, A., Singh, S., Srivastava S.K., Arora, S., Hyde, S.J., Andrews, J., Grizzle, W.E., Singh A.P. (2014). Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model. British journal of cancer. 110 (8), 2000-2010. 15. Srivastava, S.K., Arora, S., Singh, S., Bhardwaj, A., Averett, C., Singh, A.P. (2014). MicroRNAs in Pancreatic Malignancy: Progress and Promises. Cancer Letters. S0304-3835(14)00106-2. 16. Bhardwaj, A., Arora, S., Prajapati, V.K., Singh, S., and Singh, A.P. (2013). Cancer stemness-regulating miRNAs: role, mechanisms and therapeutic potential. Current Drug Targets.14 (10):1175-84. 17. Singh, A.P., Arora,S., Bhardwaj, A., Srivastava, S.K., Kadakia, M.P., Wang, B., Grizzle W.E., Owen, L,B., Singh, S (2012). CXCL12/CXCR4 signaling axis induces SHH expression in pancreatic cancer cells via ERK- and Akt- mediated activation of NF-κB: implications for bidirectional tumor-stromal interactions. Journal of Biological chemistry. 287(46):39115-24. 18. Srivastava S.K., Bhardwaj A., Singh S., Arora S., McClellan S., Grizzle W.E., Reed E., and Singh A.P. (2012). Myb overexpression overrides androgen depletion- induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration-resistance. Carcinogenesis. 33(6):1149-1157. 19. Malhi S.S., Budhiraja A., Arora S., Chaudhari K.R., Nepali K., Kumar R., Sohi H., and Murthy R.S. (2012). Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes. International Journal of Pharmaceutics. 432(1-2):63-74. 20. Srivastava S., Bhardwaj A., Singh S., Arora S., Wang B., Grizzle W.E., and Singh A.P. (2011). MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis. 32(12):1832-1839. 21. Jain, J., Arora, S., Rajwade J.M., Omray, P., Khandelwal, S., Paknikar K.M., (2009). Silver Nanoparticles in Therapeutics: Development of an Antimicrobial Gel Formulation for Topical Use. Molecular Pharmaceutics, 6 (5), 1388–1401. 22. Kale, S.N., Rajagopal, R., Arora, S., Bhayani, K.R., Rajwade, J.M., Paknikar K.M., kundaliya, D.C., Ogale, S.B., (2007) Microwave response of La0.7Sr0.3MnO3 nanoparticles for heating applications. Journal of Biomedical Nanotechnology. 3, 178-183. 23. Bhayani, K.R., Kale, S.N., Arora, S., Rajagopal, R., Mamgain, H., Kaul-Ghanekar, R., Kundaliya, D.C., Kulkarni, S.D., pasricha, R., Dhole, S.D., Ogale, S.B., Paknikar, K.M., (2007). Protein and polymer immobilized La0.7Sr0.3MnO3 nanoparticles for possible biomedical applications. Nanotechnology.18, 1-7. 24. Kale, S.N., Arora, S., Bhayani, K.R., Paknikar, K.M., Rajagopal, R., Jani, M., Wagh, U.V., Kulkarni, S.D., Ogale, S.B., (2006). Cerium doping and stoichiometry control for biomedical use of La0.7Sr0.3MnO3 nanoparticles: microwave absorption and cytotoxicity study. Nanomedicine: Nanotechnology, biology and Medicine. 2, 217-221.

Researchgroup, Institute, University, School, Company name

USAMCI, Mobile NIPER, Mohali, ISF Moga, ARI Pune

Researchgroup, Institute, Company, University, School webpage

https://www.usahealthsystem.com/our_teams

The network creator will send periodical messages to members - you below to allow us to email you

yes